Immunotherapy for ovarian cancer: what are the targets of the future?-Reference-Cited by-同舟云学术

Immunotherapy for ovarian cancer: what are the targets of the future?

Published:2015-05 Issue:9 Volume:11 Page:1293-1296
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Adams Sarah F¹,Benencia Fabian²

Affiliation:

1. Gynecologic Oncology, University of New Mexico Cancer Center, 1201 Camino de Salud, 1 University of New Mexico MSC07-4025, Albuquerque, NM 87131-0001, USA

2. Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Academic Research Center 202C, Ohio University, Athens, OH 45701, USA

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon.15.44

Reference20 articles.

1. Cancer statistics, 2015

2. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential

3. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

4. Immunologic consequences of chemotherapy for ovarian cancer: Impaired responses to the influenza vaccine

5. Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics;Frontiers in Oncology;2024-05-30

RHPN2 Promotes Malignant Cell Behaviours in Ovarian Cancer by Activating STAT3 Signalling

;OncoTargets and Therapy;2020-11

3. Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant;Frontiers in Immunology;2020-10-06

4. Long noncoding RNA DUXAP8 regulates proliferation and apoptosis of ovarian cancer cells via targeting miR-590-5p;Human Cell;2020-08-04

5. Effect of laminin environments and tumor factors on the biology of myeloid dendritic cells;Immunobiology;2020-01